The latest study on Hereditary Angioedema Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Hereditary Angioedema Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Hereditary Angioedema and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Pharming Group NV
Shire plc
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Hereditary Angioedema Market Analysis By Type Segment:
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
Hereditary Angioedema Market Analysis By Application Segment:
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Hereditary Angioedema Market Analysis By Regions (Countries):
The Hereditary Angioedema Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Hereditary Angioedema Report:
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Hereditary Angioedema Market:
Hereditary Angioedema market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Hereditary Angioedema Market status and future forecast.
To present the key Hereditary Angioedema Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Hereditary Angioedema Market Size Growth Rate by Type (2016-2027)
1.3.2 C1 Esterase Inhibitor
1.3.3 Kallikrein Inhibitor
1.3.4 Selective Bradykinin B2 Receptor Antagonist
1.4 Market Segment by Application
1.4.1 Global Hereditary Angioedema Market Share by Application (2021-2027)
1.4.2 Retail Pharmacies
1.4.3 Hospital Pharmacies
1.4.4 Online Pharmacies
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Angioedema Market Size
2.1.1 Global Hereditary Angioedema Revenue 2016-2027
2.1.2 Global Hereditary Angioedema Sales 2016-2027
2.2 Hereditary Angioedema Growth Rate by Regions
2.2.1 Global Hereditary Angioedema Sales by Regions 2016-2020
2.2.2 Global Hereditary Angioedema Revenue by Regions 2016-2020
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Hereditary Angioedema Sales by Manufacturers
3.1.1 Hereditary Angioedema Sales by Manufacturers 2020
3.1.2 Hereditary Angioedema Sales Market Share by Manufacturers 2020
3.2 Revenue by Manufacturers
3.2.1 Hereditary Angioedema Revenue by Manufacturers (2020)
3.2.2 Hereditary Angioedema Revenue Share by Manufacturers (2020)
3.2.3 Global Hereditary Angioedema Market Concentration Ratio (CR5 and HHI)
3.3 Hereditary Angioedema Price by Manufacturers
3.4 Key Manufacturers Hereditary Angioedema Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Hereditary Angioedema Market
3.6 Key Manufacturers Hereditary Angioedema Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 C1 Esterase Inhibitor Sales and Revenue (2016-2020)
4.1.2 Kallikrein Inhibitor Sales and Revenue (2016-2020)
4.1.3 Selective Bradykinin B2 Receptor Antagonist Sales and Revenue (2016-2020)
4.2 Global Hereditary Angioedema Sales Market Share by Type
4.3 Global Hereditary Angioedema Revenue Market Share by Type
4.4 Hereditary Angioedema Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Hereditary Angioedema Sales by Application
6 United States
6.1 United States Hereditary Angioedema Breakdown Data by Company
6.2 United States Hereditary Angioedema Breakdown Data by Type
6.3 United States Hereditary Angioedema Breakdown Data by Application
7 European Union
7.1 European Union Hereditary Angioedema Breakdown Data by Company
7.2 European Union Hereditary Angioedema Breakdown Data by Type
7.3 European Union Hereditary Angioedema Breakdown Data by Application
8 China
8.1 China Hereditary Angioedema Breakdown Data by Company
8.2 China Hereditary Angioedema Breakdown Data by Type
8.3 China Hereditary Angioedema Breakdown Data by Application
9 Rest of World
9.1 Rest of World Hereditary Angioedema Breakdown Data by Company
9.2 Rest of World Hereditary Angioedema Breakdown Data by Type
9.3 Rest of World Hereditary Angioedema Breakdown Data by Application
9.4 Rest of World Hereditary Angioedema Breakdown Data by Countries
9.4.1 Rest of World Hereditary Angioedema Sales by Countries
9.4.2 Rest of World Hereditary Angioedema Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Pharming Group NV
10.1.1 Pharming Group NV Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Hereditary Angioedema
10.1.4 Hereditary Angioedema Product Introduction
10.1.5 Pharming Group NV Recent Development
10.2 Shire plc
10.2.1 Shire plc Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Hereditary Angioedema
10.2.4 Hereditary Angioedema Product Introduction
10.2.5 Shire plc Recent Development
10.3 CSL Limited
10.3.1 CSL Limited Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Hereditary Angioedema
10.3.4 Hereditary Angioedema Product Introduction
10.3.5 CSL Limited Recent Development
10.4 iBio Inc.
10.4.1 iBio Inc. Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Hereditary Angioedema
10.4.4 Hereditary Angioedema Product Introduction
10.4.5 iBio Inc. Recent Development
10.5 BioCryst Pharmaceuticals, Inc.
10.5.1 BioCryst Pharmaceuticals, Inc. Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Hereditary Angioedema
10.5.4 Hereditary Angioedema Product Introduction
10.5.5 BioCryst Pharmaceuticals, Inc. Recent Development
10.6 Ionis Pharmaceuticals, Inc.
10.6.1 Ionis Pharmaceuticals, Inc. Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Hereditary Angioedema
10.6.4 Hereditary Angioedema Product Introduction
10.6.5 Ionis Pharmaceuticals, Inc. Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Hereditary Angioedema Sales Channels
11.2.2 Hereditary Angioedema Distributors
11.3 Hereditary Angioedema Customers
12 Market Forecast
12.1 Global Hereditary Angioedema Sales and Revenue Forecast 2021-2027
12.2 Global Hereditary Angioedema Sales Forecast by Type
12.3 Global Hereditary Angioedema Sales Forecast by Application
12.4 Hereditary Angioedema Forecast by Regions
12.4.1 Global Hereditary Angioedema Sales Forecast by Regions 2021-2027
12.4.2 Global Hereditary Angioedema Revenue Forecast by Regions 2021-2027
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Hereditary Angioedema Product Picture
Table Hereditary Angioedema Key Market Segments
Table Major Manufacturers Hereditary Angioedema Covered in This Report
Table Global Hereditary Angioedema Market Size Growth Rate by Type 2021-2027 (MT) & (Million US$)
Figure Global Hereditary Angioedema Sales Market Shar by Type 2016-2027
Figure C1 Esterase Inhibitor Figures
Table Major Manufacturers of C1 Esterase Inhibitor
Figure Kallikrein Inhibitor Figures
Table Major Manufacturers of Kallikrein Inhibitor
Figure Selective Bradykinin B2 Receptor Antagonist Figures
Table Major Manufacturers of Selective Bradykinin B2 Receptor Antagonist
Table Global Hereditary Angioedema Market Share by Application 2021-2027 (MT)
Figure Retail Pharmacies Use Case
Figure Hospital Pharmacies Use Case
Figure Online Pharmacies Use Case
Figure Hereditary Angioedema Report Years Considered
Figure Global Hereditary Angioedema Market Size 2016-2027 (Million US$)
Figure Global Hereditary Angioedema Sales 2016-2020 (MT)
Table Global Hereditary Angioedema Market Size by Regions 2016-2020 (MT) & (Million US$)
Table Global Hereditary Angioedema Sales by Regions 2016-2020 (MT)
Table Global Hereditary Angioedema Sales Market Share by Regions 2016-2020
Figure Global Hereditary Angioedema Sales Market Share by Regions 2016-2020
Figure Global Hereditary Angioedema Sales Market Share by Regions in 2020
Table Global Hereditary Angioedema Revenue by Regions 2016-2020 (Million US$)
Table Global Hereditary Angioedema Revenue Market Share by Regions 2016-2020
Figure Global Hereditary Angioedema Revenue Market Share by Regions 2016-2020
Figure Global Hereditary Angioedema Revenue Market Share by Regions in 2020
Table Market Top Trends
Table Global Hereditary Angioedema Sales by Manufacturers (2020) (MT)
Table Global Hereditary Angioedema Sales Share by Manufacturers (2020)
Figure Global Hereditary Angioedema Sales Share by Manufacturers in 2020
Table Hereditary Angioedema Revenue by Manufacturers (2020) (Million USD)
Table Hereditary Angioedema Revenue Share by Manufacturers (2020)
Figure Hereditary Angioedema Value Share by Manufacturers in 2020
Table Global Hereditary Angioedema Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Hereditary Angioedema Price (2016-2020) (USD/Kg)
Table Key Manufacturers Hereditary Angioedema Plants/Factories Distribution
Table Key Manufacturers Hereditary Angioedema Area Served
Table Date of Key Manufacturers Enter into Hereditary Angioedema Market
Table Key Manufacturers Hereditary Angioedema Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global C1 Esterase Inhibitor Sales and Revenue (2016-2020) (MT) & (Million US$)
Table Global Kallikrein Inhibitor Sales and Revenue (2016-2020) (MT) & (Million US$)
Table Global Selective Bradykinin B2 Receptor Antagonist Sales and Revenue (2016-2020) (MT) & (Million US$)
Table Global Hereditary Angioedema Sales by Type (2016-2020) (MT)
Table Global Hereditary Angioedema Sales Share by Type (2016-2020)
Figure Global Hereditary Angioedema Sales Market Share by Type (2016-2020)
Figure Global Hereditary Angioedema Sales Market Share by Type in 2020
Table Global Hereditary Angioedema Revenue by Type (2016-2020) (Million US$)
Table Global Hereditary Angioedema Revenue Share by Type (2016-2020)
Figure Global Hereditary Angioedema Revenue Market Share by Type (2016-2020)
Figure Global Hereditary Angioedema Revenue Market Share by Type in 2020
Table Hereditary Angioedema Price by Type 2016-2020 (USD/Kg)
Table Global Hereditary Angioedema Sales by Application (2016-2020) (MT)
Table Global Hereditary Angioedema Sales Share by Application (2016-2020)
Figure Global Sales Hereditary Angioedema Market Share by Application (2016-2020)
Figure Global Sales Hereditary Angioedema Market Share by Application (2016-2020)
Figure United States Hereditary Angioedema Sales Growth Rate 2016-2020 (MT)
Figure United States Hereditary Angioedema Revenue Growth Rate 2016-2020 (Million US$)
Table United States Hereditary Angioedema Sales by Company (2020) (MT)
Table United States Hereditary Angioedema Sales Market Share by Company (2020)
Figure United States Hereditary Angioedema Sales Market Share by Company in 2020
Table United States Hereditary Angioedema Sales by Type (2016-2020) (MT)
Table United States Hereditary Angioedema Sales Market Share by Type (2016-2020)
Figure United States Hereditary Angioedema Market Share by Type in 2020
Table United States Hereditary Angioedema Sales by Application (2016-2020) (MT)
Table United States Hereditary Angioedema Sales Market Share by Application (2016-2020)
Figure United States Hereditary Angioedema Market Share by Application in 2020
Figure European Union Hereditary Angioedema Sales Growth Rate 2016-2020 (MT)
Figure European Union Hereditary Angioedema Revenue Growth Rate 2016-2020 (Million US$)
Table European Union Hereditary Angioedema Sales by Company (2020) (MT)
Table European Union Hereditary Angioedema Sales Market Share by Company (2020)
Figure European Union Hereditary Angioedema Sales Market Share by Company in 2020
Table European Union Hereditary Angioedema Sales by Type (2016-2020) (MT)
Table European Union Hereditary Angioedema Sales Market Share by Type (2016-2020)
Figure 2020 European Union Hereditary Angioedema Market Share by Type
Table European Union Hereditary Angioedema Sales by Application (2016-2020) (MT)
Table European Union Hereditary Angioedema Sales Market Share by Application (2016-2020)
Figure 2020 European Union Hereditary Angioedema Market Share by Application
Figure China Hereditary Angioedema Sales Growth Rate 2016-2020 (MT)
Figure China Hereditary Angioedema Revenue Growth Rate 2016-2020 (Million US$)
Table China Hereditary Angioedema Sales by Company (2020) (MT)
Table China Hereditary Angioedema Sales Market Share by Company (2020)
Figure China Hereditary Angioedema Sales Market Share by Company in 2020
Table China Hereditary Angioedema Sales by Type (2016-2020) (MT)
Table China Hereditary Angioedema Sales Market Share by Type (2016-2020)
Figure China Hereditary Angioedema Market Share by Type in 2020
Table China Hereditary Angioedema Sales by Application (2016-2020) (MT)
Table China Hereditary Angioedema Sales Market Share by Application (2016-2020)
Figure China Hereditary Angioedema Market Share by Application in 2020
Figure Rest of World Hereditary Angioedema Sales Growth Rate 2016-2020 (MT)
Figure Rest of World Hereditary Angioedema Revenue Growth Rate 2016-2020 (Million US$)
Table Rest of World Hereditary Angioedema Sales by Company (2020) (MT)
Table Rest of World Hereditary Angioedema Sales Market Share by Company (2020)
Figure Rest of World Hereditary Angioedema Sales Market Share by Company in 2020
Table Rest of World Hereditary Angioedema Sales by Type (2016-2020) (MT)
Table Rest of World Hereditary Angioedema Sales Market Share by Type (2016-2020)
Figure Rest of World Hereditary Angioedema Market Share by Type in 2020
Table Rest of World Hereditary Angioedema Sales by Application (2016-2020) (MT)
Table Rest of World Hereditary Angioedema Sales Market Share by Application (2016-2020)
Figure Rest of World Hereditary Angioedema Market Share by Application in 2020
Table Rest of World Hereditary Angioedema Sales by Countries (2016-2020) (MT)
Table Rest of World Hereditary Angioedema Sales Market Share by Countries (2016-2020)
Figure Rest of World Hereditary Angioedema Sales Market Share by Countries in 2020
Table Rest of World Hereditary Angioedema Revenue by Countries (2016-2020) (Million US$)
Table Rest of World Hereditary Angioedema Revenue Market Share by Countries (2016-2020)
Figure Rest of World Hereditary Angioedema Revenue Market Share by Countries in 2020
Figure Japan Hereditary Angioedema Sales Growth Rate (2016-2020) (MT)
Figure Japan Hereditary Angioedema Revenue Growth Rate (2016-2020) (MT)
Figure Korea Hereditary Angioedema Sales Growth Rate (2016-2020) (MT)
Figure Korea Hereditary Angioedema Revenue Growth Rate (2016-2020) (MT)
Figure India Hereditary Angioedema Sales Growth Rate (2016-2020) (MT)
Figure India Hereditary Angioedema Revenue Growth Rate (2016-2020) (MT)
Figure Southeast Asia Hereditary Angioedema Sales Growth Rate (2016-2020) (MT)
Figure Southeast Asia Hereditary Angioedema Revenue Growth Rate (2016-2020) (MT)
Table Pharming Group NV Company Details
Table Pharming Group NV Description and Business Overview
Table Pharming Group NV Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2020)
Table Pharming Group NV Hereditary Angioedema Sales Growth Rate (2016-2020)
Table Pharming Group NV Hereditary Angioedema Sales Market Share in Global Market
Table Pharming Group NV Recent Development
Table Shire plc Company Details
Table Shire plc Description and Business Overview
Table Shire plc Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2020)
Table Shire plc Hereditary Angioedema Sales Growth Rate (2016-2020)
Table Shire plc Hereditary Angioedema Sales Market Share in Global Market
Table Shire plc Recent Development
Table CSL Limited Company Details
Table CSL Limited Description and Business Overview
Table CSL Limited Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2020)
Table CSL Limited Hereditary Angioedema Sales Growth Rate (2016-2020)
Table CSL Limited Hereditary Angioedema Sales Market Share in Global Market
Table CSL Limited Recent Development
Table iBio Inc. Company Details
Table iBio Inc. Description and Business Overview
Table iBio Inc. Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2020)
Table iBio Inc. Hereditary Angioedema Sales Growth Rate (2016-2020)
Table iBio Inc. Hereditary Angioedema Sales Market Share in Global Market
Table iBio Inc. Recent Development
Table BioCryst Pharmaceuticals, Inc. Company Details
Table BioCryst Pharmaceuticals, Inc. Description and Business Overview
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2020)
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales Growth Rate (2016-2020)
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales Market Share in Global Market
Table BioCryst Pharmaceuticals, Inc. Recent Development
Table Ionis Pharmaceuticals, Inc. Company Details
Table Ionis Pharmaceuticals, Inc. Description and Business Overview
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2020)
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales Growth Rate (2016-2020)
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales Market Share in Global Market
Table Ionis Pharmaceuticals, Inc. Recent Development
Figure Hereditary Angioedema Value Chain
Table Hereditary Angioedema Distributors List
Table Hereditary Angioedema Customers List
Table Global Hereditary Angioedema Sales Forecast 2021-2027 (MT) & (Million US$)
Figure Global Hereditary Angioedema Sales Forecast 2021-2027 (MT)
Figure Global Hereditary Angioedema Revenue Forecast 2021-2027 (Million US$)
Table Global Hereditary Angioedema Sales Forecast by Type 2021-2027 (MT)
Figure Global Hereditary Angioedema Sales Forecast by Type 2021-2027 (MT)
Figure Global Hereditary Angioedema Sales Market Share Forecast by Type 2021-2027
Table Global Hereditary Angioedema Sales Forecast by Application 2021-2027 (MT)
Figure Global Hereditary Angioedema Sales Forecast by Application 2021-2027 (MT)
Figure Global Hereditary Angioedema Sales Market Share Forecast by Application 2021-2027
Table Global Hereditary Angioedema Sales Forecast by Regions 2021-2027 (MT)
Figure Global Hereditary Angioedema Sales Forecast by Regions 2021-2027 (MT)
Figure Global Hereditary Angioedema Sales Market Share Forecast by Regions 2021-2027
Table Global Hereditary Angioedema Revenue Forecast by Regions 2021-2027 (MT)
Figure Global Hereditary Angioedema Revenue Forecast by Regions 2021-2027 (MT)
Figure Global Hereditary Angioedema Revenue Market Share Forecast by Regions 2021-2027
Figure United States Hereditary Angioedema Sales Forecast 2021-2027 (MT)
Figure United States Hereditary Angioedema Revenue Forecast 2021-2027 (Million US$)
Figure European Union Hereditary Angioedema Sales Forecast 2021-2027 (MT)
Figure European Union Hereditary Angioedema Revenue Forecast 2021-2027 (Million US$)
Figure China Hereditary Angioedema Sales Forecast 2021-2027 (MT)
Figure China Hereditary Angioedema Revenue Forecast 2021-2027 (Million US$)
Figure Japan Hereditary Angioedema Sales Forecast 2021-2027 (MT)
Figure Japan Hereditary Angioedema Revenue Forecast 2021-2027 (Million US$)
Figure Korea Hereditary Angioedema Sales Forecast 2021-2027 (MT)
Figure Korea Hereditary Angioedema Revenue Forecast 2021-2027 (Million US$)
Figure India Hereditary Angioedema Sales Forecast 2021-2027 (MT)
Figure India Hereditary Angioedema Revenue Forecast 2021-2027 (Million US$)
Figure Southeast Asia Hereditary Angioedema Sales Forecast 2021-2027 (MT)
Figure Southeast Asia Hereditary Angioedema Revenue Forecast 2021-2027 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources